SEQUANA news, videos and press releases
For more news please use our advanced search feature.
SEQUANA - More news...
SEQUANA - More news...
-
Sequana Medical - executive interview
-
Sequana Medical – Executive Interview
-
Sequana Medical – executive interview
- Sequana Medical announces 2019 Full Year Results and 2020 Outlook
- Sequana Medical Notice of 2019 Full Year Results and 2020 Outlook
- Transparency Notifications from Shareholders
- Transparency Notifications from Shareholders
- Sequana Medical Announces New Share Capital Amount and New Number of Shares
- Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement
- SEQUANA MEDICAL LAUNCHES EQUITY PLACEMENT
- Sequana Medical announces first-in-human data of Direct Sodium Removal (DSR) therapy published in Circulation
- Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients
- Sequana Medical announces 2019 Half Year Results and Year-to-date Business Update
- Sequana Medical announces first patient enrolled in North American alfapump® pivotal study (POSEIDON)
- Sequana Medical appoints leading experts as Heart Failure Scientific Advisors
- Sequana Medical announces date change for Half Year 2019 Business Update and Financial Results
- Sequana Medical announces unconditional IDE approval from U.S. FDA to start alfapump® pivotal study (POSEIDON)
- Sequana Medical announces presentation of positive DSR clinical proof-of-concept data demonstrating potential in volume overload due to heart failure
- Sequana Medical announces results of Annual General Meeting of Shareholders
- Sequana Medical to host webcast on 27 May 2019
- Sequana Medical announces 2018 Full Year Results and 2019 Outlook
- Extraordinary General Shareholders' Meeting to be held on 25 April 2019
- Sequana Medical announces the end of the stabilisation period of its offering
- Evolution of the Safeguard procedure of Sequana
- Sequana Medical: Mid-Stabilisation Period Announcement
- Sequana Medical NV: Disclosure of Outstanding Voting Securities
- Sequana Medical raises €27.5 million in successful Initial Public Offering
- Sequana Medical announces the Coverage of the Base Offering of Its Initial Public Offering on Euronext Brussels
- The Court of Appeal in London confirms for the largest part the decision made in first instance by the High Court of Justice in the litigation between Sequana and British American Tobacco (BAT)
- Some of Arjowiggins' companies in the UK plan to enter into administration
